Business · 22/10/2024Updated: 10/17/2026 · 1 min read
FDA Extends Comment Period for Draft Guidance on Medical Device Biocompatibility
Summary
The Food and Drug Administration (FDA) is extending the comment period for its draft guidance on chemical analysis for biocompatibility assessment of medical devices, in response to a request for an extension from interested persons.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →